Draft May 6, 2011
Global Academic Programs 2011 Conference
May 31st – June 2, 2011
Hickey Auditorium and Anderson Conference Hall
Program Agenda
Tuesday, May 31, 2011
8:00 – 8:05 AM
8:05 – 8:35 AM
Opening Address (Hickey Auditorium)
Raymond N. DuBois, M.D. Ph.D.
Provost and Executive Vice President
Oliver Bogler, Ph.D, Professor of Neurosurgery
Vice President, Global Academic Programs
Keynote Address
Tumor Resequencing
Richard Gibbs, Ph.D., Director and Wofford Cain Professor
BCM-Human Genome Sequencing Center
Department of Molecular and Human Genetics
Baylor College of Medicine
8:35 – 8:45 AM
Large-scale Sequencing of Tumors in Hospital AC Camargo
Emmanuel Dias-Neto, Ph.D.
Head, Medical Genomics and Bioinformatics
AC Camargo Cancer Hospital – Sao Paulo, Brazil
8:45 – 8:55 AM
Genomic Sequencing of Human Primary Brain Tumors
Daniel Patrick Cahill, M.D., Ph.D.
Assistant Professor, Neurosurgery
UT M.D. Anderson Cancer Center
8:55 – 9:05 AM
Tmprss2: Erg Gene-Fusion Promotes Epithelial to
Mesenchymal Transition in Immortalized Human Prostate
Transition Epithelial Cells
Raanan Berger, M.D., Ph.D.
Senior Oncologist
Sheba Medical Center – Tel Hashomer, Israel
9:05 – 9:15 AM
High-Throughput Sequencing-Based Small RNA Identification
for Biomarker Discovery in Oral Squamous Cell Carcinoma
Patricia Severino, Ph.D
Functional Genomics, Education & Research Institute
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
9:15 – 10:30 AM
Biomarkers and Gene Expression (Hickey Auditorium)
Session Chair, Kenneth D. Aldape, M.D.
1
Draft May 6, 2011
Professor, Pathology
UT M.D. Anderson Cancer Center
9:15 – 9:25 AM
Visualizing Mutations: Development of IDH1 and BRAF
Mutation Specific Antibodies
David Capper, M.D., Resident, Neuropathology
Heidelberg University Hospital and German Cancer Research
Center (DKFZ) – Heidelberg, Germany
9:25 – 9:35 AM
Molecular Aspects of Breast Cancer: Insights From Gene
Expression Studies
Dirce Carraro, Ph.D.
Coordinator of Nucleic Acid Bank
Head, Laboratory of Molecular Biology
AC Camargo Cancer Hospital – Sao Paulo, Brazil
9:35 – 9:45 AM
TP53 Mutations as Biomarkers for Cancer Detection,
Prognosis and Therapy
Pierre Hainaut, Ph.D.
Head, Molecular Carcinogenesis
International Agency for Research on Cancer – Lyon, France
9:45 – 9:55 AM
Pharmacogenomic Biomarker Development in Gastric Cancer
Sun Young Rha, M.D.
Yonsei Cancer Center – Seoul, Korea
9:55 – 10:05 AM
The Wilms’ Tumor Initiating Cell Is An NCAM Cell Enriched
for ALDH1 Activity and Possessing Renal Stem Cell
Characteristics That Can Be Targeted in Vivo
Benjamin Dekel, M.D.
Professor
Sheba Medical Center – Tel Hashomer, Israel
10:05 – 10:15 AM
Oncogenetics at Albert Einstein Hospital: Patient Care,
Education and Research
Fernanda Teresa de Lima, M.D., Ph.D.
Medical Oncology Cancer Genetics
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
10:30 – 10:45 AM
Coffee Break
10:45 – 12:30 PM
Drug and Technology Research and Development
(Hickey Auditorium)
Session Chair, Garth Powis, DPHIL
Professor and Chair, Experimental Therapeutics
UT M.D. Anderson Cancer Center
2
Draft May 6, 2011
10:45 – 11:00 AM
*Young Investigator Travel Award*
MRI for Depiction of Subtle BBB Opening in Glioblastoma
Multiforme Patients
Yael Mardor, M.D.
Sheba Medical Center – Tel Hashomer, Israel
11:00 – 11:15 AM
KLOTHO: From Hormone to Novel Cancer Therapy
Ido Wolf, M.D.
Senior Oncologist
Sheba Medical Center – Tel Hashomer, Israel
11:15 – 11:30 AM
STIL Regulates Mitotic Entry and Centrosomal Formation
Through Regulation of the CHFR Tumor Suppressor Protein
Shai Izraeli, M.D.
Associate Professor
Sheba Medical Center – Tel Hashomer, Israel
11:30 – 11:45 AM
Good Clinical Practice (GCP) Center in China
Yuanki Shi, M.D.
Professor and Vice President
Chinese Academy of Medical Sciences (CAMS) Cancer Institute &
Hospital – Beijing, China
11:45 – 12:00 PM
*DKFZ SINF Award*
Intensity modulated particle therapy
Uwe Oelfke, Ph.D.
Medical Physics, Radiation Therapy
German Cancer Research Center (DKFZ) – Heidelberg, Germany
Radhe Mohan, Ph.D.
Professor, Radiation Physics – Patient Care
UT M.D. Anderson Cancer Center
12:30 – 2:00 PM
Lunch
GAP Business Meeting (all are invited)
o Norway Cancer Registry
o GAP 2012 Conference (Oslo, Norway) – May 12 - 17
o GAP Network and GAP Connect
o Sister Institution Network Fund (SINF)
Hickey Auditorium
2:00 – 5:00 PM
Global Clinical Trials Research (Hickey Auditorium)
Session Chair, Hagop M. Kantarjian, M.D.
Professor and Chair, Leukemia
Associate Vice President for Clinical Research, GAP
3
Draft May 6, 2011
2:00 – 2:15 PM
New Drugs, Pathways, Shared Protocols, Infrastructure
Hagop M. Kantarjian, M.D., Professor and Chair, Leukemia
Associate Vice President for Clinical Research, GAP
2:15 – 2:30 PM
Inflammatory Breast Cancer Registry
National Cancer Institute of Peru – Lima, Peru
Tatiana Vidaurre, M.D., Chief, Support Services
Ricardo Alvarez, M.D., Assistant Professor, Breast Medical
Oncology
Vicente Valero, M.D., Professor and Deputy Chair, Breast
Medical Oncology
2:30 – 2:45 PM
Implementation of Biomarker Driven Clinical Trial In
Nasopharyngeal Carcinoma
Chinese University of Hong Kong – Hong Kong, China
Edwin P. Hui, M.D., Director, Comprehensive Cancer Trials Unit
Kian Ang, M.D., Ph.D., Professor, Radiation Oncology
2:45 – 3:00 PM
High Risk Germ-Cell Tumor Study
Institute Gustave Roussy – Villejuif, France
Lance Pagliaro, M.D., Associate Professor, Genitourinary
Medical Oncology
3:00 – 3:15 PM
Clinical Trials: Starting a Local Network and Collaboration
with M.D. Anderson Cancer Center
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
Oren Smaletz, M.D., Medical Oncologist, Coordinator, Oncology
Clinical Trials Office
3:15 – 3:30 PM
Development of IND Based International Investigator Breast
Cancer Clinical Trials
Tokyo Oncology Consortium – Tokyo, Japan
Teruo Yamauchi, M.D.
Naoto Ueno, M.D. Ph.D., Professor, Breast Medical Oncology
3:30 – 3:45 PM
MDACC / INEN Prior and Current Breast Cancer Trials
National Cancer Institute of Peru – Lima, Peru
Tatiana Vidaurre, M.D., Chief, Support Services
Vicente Valero, M.D., Professor and Deputy Chair, Breast
Medical Oncology
3:45 – 4:00 PM
Phase I Study of Ofatumumab for Purging in Large
Cell Lymphoma
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
Clinica Alemana – Santiago, Chile
4
Draft May 6, 2011
Guilherme Perini, M.D., Lymphoma
Alejandro Majlis, M.D., Head of Hematology
Marcos de Lima, M.D., Professor, Stem Cell Transportation
4:00 – 4:15 PM
A Prospective Study of Conservative Surgery For Early Stage
Cervical Cancer
Clinica Alemana – Santiago, Chile
CA person to be determined
Kathleen Schmeler, M.D., Assistant Professor, Gynecologic
Oncology
4:15 – 4:30 PM
A Phase III International Randomized Trial of Open vs.
Minimally Invasive Surgery For Cervical Cancer
Instituto de Cancerologia Las Americas – Medellin, Colombia
Rene Pareja, M.D., Gynecology
Pedro Ramirez, M.D., Associate Professor, Gynecologic Oncology
4:30 – 4:45 PM
Global Clinical Trials Gastric Cancer Collaborative Project
Hyun Cheol Chung, M.D., Ph.D.
Medical Oncology
Yonsei Cancer Center
Garth Powis, Ph.D., Chair and Professor, Experimental
Therapeutics
4:45 – 5:00 PM
A Vision for the Future - Multimedia Structured Reporting
David Vinning, M.D.
Professor, Diagnostic Radiology
UT M.D. Anderson Cancer Center
5:00 - 5:30 PM
Collaboration Discussion
5:30 – 5:45 PM
Welcome Address (Hickey Auditorium)
John Mendelsohn, M.D.
President
UT M.D. Anderson Cancer Center
5:45 – 7:30 PM
Welcome Reception
Anderson Conference Hall
Wednesday, June 1, 2011
8:00 – 10:00 AM
Plenary Session - Signal Transduction (Hickey Auditorium)
Mien-Chie Hung, Ph.D.
Professor and Chair, Molecular and Cellular Oncology
UT M.D. Anderson Cancer Center
5
Draft May 6, 2011
8:00 – 8:25 AM
Cancer Biomarkers in Neuro-Oncology
Rui Reis, Ph.D.
Director of Research and Coordinator of Molecular Oncology
Research Lab
Barretos Cancer Hospital – Barretos, Brazil
8:25 – 8:50 AM
The Integrated EGFR, Wnt, and Integrin Signaling in Tumor
Cell Migration, Invasion, and Metastasis
Zhimin (James) Lu, Ph.D.
Associate Professor, Neuro-Oncology
UT M.D. Anderson Cancer Center
8:50 – 9:15 AM
Endocytic Protein: Master Regulator of Cell Signalling
Guoguang Ying, Ph.D.
Professor, Deputy Director
Tianjin Cancer Research Institute – Tianjin, China
9:15 – 9:40 AM
Epigenetic Regulation of Neuron Differentiation From
Mesenchymal Stem Cells By Polycomb Group Protien EZH2
Alan Yung-Luen Yu, Ph.D.
Associate Research Fellow, Center for Molecular Medicine
China Medical university Hospital – Taichung, Taiwan
8:00 – 10:00 AM
Sister Institution Network Fund (SINF) Program Committee
Meeting (only your designated SINF program committee member
can attend – this a closed meeting)
Anderson Conference Hall, Rooms 1 and 2
10:00 – 10:15 AM
Coffee Break
Simultaneous Break-Out Sessions
10:15 – 1:00 PM
Frontiers In Gastrointestinal and Hepatobiliary Cancers
(Searle’s Conference Room)
Session Chair, Lopa Mishra, M.D.
Professor and Chair, Gastroenterology, Hepatology & Nutrition
UT M.D. Anderson Cancer Center
10:15 – 10:30 AM
Molecular Targets and Opportunities: Tumor Initiating Stem
Cells In Gastrointestinal and Hepatocellular Cancer
Lopa Mishra, MD
Chair and Professor, Department of Gastroenterology,
Hepatology, & Nutrition
The University of Texas MD Anderson Cancer Center
6
Draft May 6, 2011
10:30 – 10:45 AM
Education and Imaging in Liver and Pancreatic Cancers in
India at a GEMS Institute
C.E. Eapen, MD
Professor of Gastroenterology and Hepatology
Christian Medical College, Vellore, India
10:45 – 11:00 AM
Hepatocellular Cancer: A Global Perspective
Shiv Sarin, MD
Chairman of the Medical Council of India (MCI)
Professor and Head, Department of Hepatology, & Director,
Institute of Liver and Biliary Sciences (ILBS)
GB Pant Hospital, New Delhi, India
11:00 – 11:15 AM
Biliary Cancers: New Advances
Ivan Roa, MD
Chief, Department of Pathology
Clinica Alemana de Santiago – Santiago, Chile
11:15 – 11:30 AM
Colon Cancer – High Risk Cancer Registry and Advances in
FAP
Patrick Lynch, JD, MD
Professor, Department of Gastroenterology, Hepatology, &
Nutrition
The University of Texas MD Anderson Cancer Center
11:30 – 11:45 AM
New Horizons in Cancer Prevention – for GI and
Hepatobiliary Cancers
Powel Brown, MD, PhD
Chair and Professor, Clinical Cancer Prevention
The University of Texas MD Anderson Cancer Center
11:45 – 12:00 PM
Laparasocopy Versus Robotic TME for Rectal Cancer: A
Prospective Randomized Trial
Antonio Luiz de Vasconcellos Macedo, M.D.
General Surgeon, President, Oncology Council
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
12:00 – 12:15 PM
Response Predictors for Neoadjuvant Treatment in Rectal
Cancer
Samuel Aguiar Jr, M.D., Ph.D.
Surgical Oncology
AC Camargo Hospital – Sao Paulo, Brazil
12:15 – 12:30 PM
Chemoradiotherapy For Colorectal Cancer: Results From
Prospective Randomized Nordic Trials
Kjell Magne Tveit, M.D.
Professor and Head of Department of Oncology
7
Draft May 6, 2011
Oslo University Hospital – Olso, Norway
12:30 – 12:45PM
Surgical Treatment of Hepatocellular Carcinoma
Qiang Li, M.D.
Vice President
Tianjin Medical University Cancer Institute – Tianjin, China
Collaboration Discussion
10:15 – 12:30 PM
Breast Cancer (Hickey Auditorium)
Session Chair, Banu K. Arun, M.D.
Professor, Breast Medical Oncology
UT M.D. Anderson Cancer Center
10:15 – 10:35 AM
The Application of a Modified Gail Model in Estimating the
Risk for Developing Breast Cancer Among Jordanian Women
Luna Al-Zaru, M.D.
Director, Office of Clinical Research and Cancer Registry
King Hussein Cancer Center – Amman, Jordan
10:35 – 10:55 AM
The Glucagon-like Peptide (GLP)-1 and Exendin-4: Activators
of cAMP and Novel Growth Inhibitors of Breast Cancer Cells
Tami Rubinek, Ph.D.
Sheba Medical Center – Tel Hashomer, Israel
10:55 – 11:15 AM
Higher Expression of Androgen Receptor as a Significant
Predictor for Better Endocrine-responsiveness in Estrogen
Receptor-Positive Breast Cancers
Se-ho Park, M.D., Ph.D.
Surgery
Yonsei University Medical Center – Seoul, South Korea
11:15 – 11:35 AM
Effects of An mTOR Inhibitor RAD001 on Human Breast
Cancer Stem Cells In Vitro and In Vivo
Jin Zhang, M.D.
Director, Breast Cancer Center
Tianjin Medical University Cancer Institute and Hospital –
Tianjin, China
11:35 – 11:55 AM
Breast Cancer Patient Satisfaction With Reconstruction: Arab
Women Experience
Firas F. AL-Ahmad, MD, MRCS
Surgical Oncology Fellow, Department of Surgery
King Hussein Cancer Center – Amman, Jordan
8
Draft May 6, 2011
11:55 – 12:15 PM
Breast Cancer Epigenomics: Evidence for “Epigenetic
Switching” in Breast Cancer Cells Using Next Generation
Sequencing Technologies
Einav Nili Gal-Yam, M.D., Ph.D.
Clinical Oncologist & Cancer Epigenetics Specialist
Sheba Medical Center – Tel Hashomer, Israel
Collaboration Discussion
10:15 – 12:30 PM
Hematologic Malignancies
(Anderson Conference Hall, Rooms 3 and 4)
Session Chair, Marcos J. de Lima, M.D.
Professor, Stem Cell Transplantation
UT M.D. Anderson Cancer Center
10:15 – 10:30 AM
Implications of Microenvironment Interactions in Multiple
Myeloma (MM) and Chronic Lymphocytic Leukemia (CLL):
The Role of CXCR4/CXCL12 Chemokine Pathway
Katia Beider, Ph.D.
Sheba Medical Center – Tel Hashomer, Israel
10:30 – 10:45 AM
Oral or IV BFLU as a Conditioning Regimen for Myeloid
Diseases at Albert Einstein
Fabio Kerbauy, M.D.
Hematology
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
10:45 – 11:00 AM
Azacitidine 100mg Fixed Daily Dose for the Treatment and
Retreatment of Patients with Myelodysplastic Syndrome and
Acute Myeloid Leukemia
Su-Peng Yeh, M.D.
Associate Professor
China Medical University Hospital – Taichung, Taiwan
11:00 – 11:15 AM
A Randomised, Open-Label, Multicentre Phase III Study of
the Combination of Rituximab, Cyclophosphamide,
Doxorubicin, VELCADE, and Prednisone (VcRCAP) or
Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and
Prednisone (RCHOP) in Patients With Newly Diagnosed
Mantle Cell Lymphoma Who Are Not Eligible for a Bone
Marrow Transplant
Huanqing Wang, M.D.
Director, Lymphoma Department
Tianjin Medical University Cancer Institute and Hospital –
Tianjin, China
9
Draft May 6, 2011
11:15 – 11:30 AM
*DKFZ SINF Award*
Deciphering the Role of Non-coding RNA in Chronic
Lymphocytic Leukemia
Thorsten Zenz, Translational Oncology
German Cancer Research Center (DKFZ) – Heildelberg, Germany
George A. Calin, M.D., Ph.D.
Associate Professor, Experimental Therapeutics
UT M.D. Anderson Cancer Center
11:30 – 11:45 AM
Research Profile for the Lymphoma Program at the
Norwegian Radium Hospital
Harald Holte, M.D.
Professor, Head of Lymphoma Program
Norwegian Cancer Consortium – Oslo, Norway
11:45 – 12:00 PM
R-ESHAP As Salvage Therapy In Chinese Patients With
Relapsed Or Refractory Diffuse Large B-cell Lymphoma: A
Prospective Phase II Study
Kai Xue, M.D.
Professor
Fudan University Cancer Hospital – Shanghai, China
Collaboration Discussion
10:15 – 12:30 PM
Pain and Supportive Care
(Anderson Conference Hall, Rooms 5 and 6)
Session Chairs
Thomas W. Feeley, M.D.
Professor and Division Head, Anesthesiology and Critical Care
UT M.D. Anderson Cancer Center
Eduardo Bruera, M.D.
Professor and Chair, Palliative Care & Rehabilitation Medicine
10:15 – 11:00 AM
Pain Management Experience at King Hussein Cancer Center
(KHCC)
Hussein Abu Khudair, M.D.
Chairman, Department of Anesthesia & Pain Management
King Hussein Cancer Center – Amman, Jordan
11:00 – 11:45 AM
Pain Management at M.D. Anderson Cancer Center
Larry C. Driver, M.D.
Chair Ad Interim and Professor, Pain Medicine
UT M.D. Anderson Cancer Center
11:45 – 12:30 PM
Supportive and Palliative Care at M.D. Anderson Cancer
Center
10
Draft May 6, 2011
David Hui, M.D.
Assistant Professor, Palliative Care and Rehabilitation Medicine
UT M.D. Anderson Cancer Center
Collaboration Discussion
10:15 – 12:30 PM
Tumor Resequencing Workshop
(To be held at the Genome Center at Baylor College of Medicine)
David A. Wheeler, Ph.D.
Professor, Human Genome Sequencing Center
Department of Molecular & Human Genetics
Baylor College of Medicine
Collaboration Discussion
12:30 – 2:00 PM
Lunch at Trevisio Restaurant
6550 Bertner Avenue
Houston, Texas 77030
713-749-0400
2:00 – 3:30 PM
Plenary Session – Personalized Medicine (Hickey Auditorium)
2:00 – 2:30 PM
Evolution of Personalized Medicine In Non-Small Cell Lung
Cancer (NSCLC)
Edward S. Kim, M.D., Associate Professor
Thoracic / Head & Neck Medical Oncology
UT M.D. Anderson Cancer Center
2:30 – 2:45 PM
Personalized Medicine Program at IGR: The Models of
Myeloproliferative Diseases, Lung and Breast Cancers
Thomas Tursz, M.D., Ph.D.
Honorary Director General
Institute Gustave Roussy – Villejuif, France
2:45 – 3:00 PM
The WIN Consortium
Vladimir Lazar, M.D., Ph.D.
Head of Genomic Research Centre
Chief Operating Officer WIN Consortium
WIN Secretary Office at Institut Gustave Roussy
Institut Gustave Roussy - Villejuif, France
3:00 – 3:15 PM
Clinical Responses Using Adoptive Transfer of Young Tumor
Infiltrating Lymphocytes in Metastatic Melanoma Patients
Michal J. Besser, Ph.D.
Head of Clinical Lab
Sheba Medical Center – Tel Hashomer, Israel
11
Draft May 6, 2011
3:30 – 3:45 PM
Coffee Break
3:45 – 5:15 PM
Simultaneous Break-Out Sessions
3:45 – 5:15 PM
Genitourinary Malignancies
(Anderson Conference Hall, Rooms 1 and 2)
Session Chair, Deborah Kuban, M.D.
Professor, Radiation Oncology
UT M.D. Anderson Cancer Center
3:45 – 4:00 PM
The Proton Therapy Center at M.D. Anderson
Andrew Lee, M.D., MPH
Associate Professor, Radiation Oncology
Medical Director, Proton Therapy Center
UT. M.D. Anderson Cancer Center
4:00 – 4:15 PM
Pentafecta: A New Concept for Reporting Outcomes of RobotAssisted Laparoscopic Radical Prostatectomy
Rafael Ferreira Coelho, M.D.
Urologist and Proctor of Robotic Surgery
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
4:15 – 4:30 PM
Ethnic Differences in Treating mRCC with Targeted Agents
Sun Young Rha, M.D.
Professor
Yonsei Cancer Center
4:30 – 4:45 PM
Prognostic Molecular Markers in Non-Muscle Invasive
Bladder Cancer: Results and Perspectives
Mario Fernandez, M.D.
Urology
Clinica Alemana – Santiago, Chile
4:45 – 5:00 PM
*Young Investigator Travel Award*
Association of Polymorphisms and Expression of ERCC1 and
XPA With The Response of Patients With Testicular Germ
Cell Tumors Treated With Cisplatin
Julia R. Mendoza Perez, M.D.
National Cancer Institute (INCan) – Mexico City, Mexico
5:00 - 5:15 PM
Title to be confirmed
Fady Geara, M.D.
Professor and Chairman, Department of Radiation Oncology
Amercian University of Beruit - Beruit, Lebanon
12
Draft May 6, 2011
Collaboration Discussion
3:45 – 5:15 PM
Head & Neck/Thoracic Cancers
(Anderson Conference Hall, Rooms 3 and 4)
Session Chair, Merrill S. Kies, M.D.
Professor, Thoracic/Head & Neck Medical Oncology
UT M.D. Anderson Cancer Center
3:45 – 3:55 PM
Epigenetic Markers in Saliva for Diagnosis and Prognosis of
Head and Neck Cancer Patients
Andre Lopes Carvalho, M.D., Ph.D.
Research Director, Chief, Head & Neck Cancers
Barretos Cancer Hospital – Barretos, Brazil
3:55 – 4:05 PM
AC Camargo Hospital Experience in the Treatment of Oral
Cancer
Luiz Paulo Kowalski, M.D., Ph.D.
Director, Head & Neck Surgery and Otorhinolaryngology
AC Camargo Cancer Hospital – Sao Paulo, Brazil
4:05 – 4:15 PM
The Susceptibility Genes of NasoPharyngeal Carcinoma
Jin-Xin Bei, M.D.
Associate Professor
Sun Yat-Sen University Cancer Center – Guangzhou, China
4:15– 4:25 PM
Novel Therapeutic Strategies in Nasopharyngeal Cancer
Herbert Loong, M.D.
Honorary Clinical Tutor
Chinese University of Hong Kong – Hong Kong, China
4:25 – 4:45 PM
Lung Cancer in Brazil: Characteristics & Challenges
Ricardo Sales dos Santos, M.D.
Head, Minimally Invasive Thoracic Surgery
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
4:45 – 4:55 PM
The Cyberknife Treatment for Early Stage Lung Cancer
Yuan Zhiyong, M.D.
Director, Radiotherapy Department
Tianjin Medical University Cancer Institute and Hospital –
Tianjin, China
Collaboration Discussion
13
Draft May 6, 2011
3:45 – 5:15 PM
Gynecologic Malignancies
(Anderson Conference Hall, Rooms 5 and 6)
Session Chair, Pedro Tomas Ramirez, M.D.
Associate Professor, Gynecologic Oncology
UT M.D. Anderson Cancer Center
3:45 - 3:50 PM
Introduction
Pedro T. Ramirez, M.D.
Assistant Professor, Gynecologic Oncology
UT M.D. Anderson Cancer Center
3:50 – 4:00 PM
*Young Investigator Travel Award*
The Biphasic Role of NF-kB in Tumor Progression and
Chemoresistance of Ovarian Cancer
Gong Yang
Fudan University Shanghai Cancer Center – Shanghai, China
4:00 – 4:05 PM
Discussion of Young Investigator Travel Award Abstract
Alpa Nick, M.D.
Assistant Professor, Gynecologic Oncology
UT M.D. Anderson Cancer Center
4:05 – 4:20 PM
A Pilot Study Using Optimal Imaging for Cervical Cancer
Screening in Brazil
Jose Humberto Fregnani, M.D.
Chief, Gynecologic Oncology
Barretos Cancer Hospital – Barretos, Brazil
4:20 – 4:40 PM
Challenges of Prospective, International Multi-Institutional
Trials
Kathleen M. Schmeler, M.D.
Assistant Professor, Gynecologic Oncology
UT M.D. Anderson Cancer Center
Pedro T. Ramirez, M.D.
Assistant Professor, Gynecologic Oncology
UT M.D. Anderson Cancer Center
4:40 – 5:00 PM
Collaborations with MD Anderson: The Collaborator's
Perspective
Rene Pareja, M.D., Gynecology
Instituto de Cancerologia IDC Las Americas – Medellin, Colombia
David Cantu, M.D., Gynecology
Instituto Nacional de Cancerologia – Mexico City, Mexico
Jose Humberto Fregnani, M.D.
Barretos Cancer Hospital – Barretos, Brazil
14
Draft May 6, 2011
5:00 – 5:15 PM
Collaboration Discussion
5:15 – 7:00 PM
Wine and Cheese Reception – Hickey Foyer
Poster Session (keep posters up thru next morning)
Thursday, June 2, 2011
8:00 – 10:30 AM
Plenary Session – Cancer Prevention (Hickey Auditorium)
Ernest Hawk, M.D., VP, Cancer Prevention & Population Sciences
UT M.D. Anderson Cancer Center
8:00 – 8:15 AM
Challenges In Cancer Prevention Programs: Resource
Constrained Settings
Surendra S. Shastri, M.D.
Head, Preventive Oncology
Tata Memorial Centre – Mumbai, India
8:15 – 8:30 AM
Is Community Intervention in Breast Cancer Screening in
Brazil Feasible?
Edmundo Mauad, M.D., Ph.D.
Medical Director and Head of Prevention
Barretos Cancer Hospital – Barretos, Brazil
8:30 – 8:45 AM
HPV Vaccination: Preliminary Results of a School-Based
Project Designated b y the Barretos Cancer Hospital, Brazil
Jose Humberto Fregnani, M.D., Ph.D.
Head, Gynecologic Oncology
Barretos Cancer Hospital – Barretos, Brazil
8:45 – 9:00 AM
International Networks for Global Prevention Research: The
Next Generation
Pierre Hainaut, Ph.D.
Head of Molecular Carcinogenesis
International Agency for Research on Cancer – Lyon, France
9:00 – 9:15 AM
Coffee Break
9:15 – 9:30 AM
Smoking Prevention in Youth: A Spectrum of Intervention
Approaches
Karen Sue Calabro, Ph.D.
Population Sciences Fellow
UT M.D. Anderson Cancer Center
Alexander V. Prokhorov, M.D., Ph.D.
Professor and Director, Tobacco Outreach Education Program
15
Draft May 6, 2011
Director, eHealth Technology Program
Department of Behavioral Science
Division of Cancer Prevention and Population Sciences
UT M.D. Anderson Cancer Center
9:30 – 9:45 AM
The Framework Convention Treaty and Tobacco Policies
Around the World
Joel S. Dunnington, M.D.
Professor, Diagnostic Radiology, Director, GI Radiology
UT M.D. Anderson Cancer Center
9:45 – 10:00 AM
Smoking Cessation in Cancer Patients and Other Chronic
Disease Populations
Ellen R. Gritz, Ph.D.
Professor and Chair, Behavioral Science
UT M.D. Anderson Cancer Center
10:00 – 10:30 AM
Collaboration Discussion
10:30 – 10:45 AM
Coffee Break
10:45 – 12:30 PM
Simultaneous Break–Out Sessions
Survivorship (Anderson Conference Hall, Rooms 3 and 4)
Session Chair, Michele Forman, PH.D.
Professor, Epidemiology
UT M.D. Anderson Cancer Center
10:45 – 11:05 AM
Developing a Cancer Survivorship Programme at Tata
Memorial Hospital Using ACT (After Completion Therapy)
Clinic for Long Term Survivors of Childhood Cancer as a
Model
Purna A. Kurkure, M.D.
Professor & Head of Pediatric Oncology, Coordinator, ACT Clinic
Tata Memorial Hospital – Mumbai, India
11:05 – 11:25 AM
The Problems Caused By Curing Testicular Cancer (TC) and
urvivorship
Sophie Fossa, M.D.
Professor
The Norwegian Radium Hospital – Oslo, Norway
11:25 – 11:45 AM
Fertility After Childhood Cancer: A Registry-based Study
Milada Cvancarova, M.Sc.
Statistician
The Norwegian Radium Hospital – Oslo, Norway
16
Draft May 6, 2011
11:45 – 12:05 PM
Buiding An Integrated Cancer Survivorship Research
Portfolio: Challenges and Opportunities
Guadalupe Palos, MSW, DRPH, BS, LMSW, RN
Manager, Clinical Protocol Administration, Cancer Survivorship
UT M.D. Anderson Cancer Center
Collaboration Discussion
10:45 – 12:30 PM
International Perspective on Integrative Oncology
(Hickey Auditorium)
Session Chair, Lorenzo Cohen, Ph.D.
Professor, General Oncology
UT M.D. Anderson Cancer Center
10:45 – 11:05 AM
Chinese Medicine in Oncology: Clinical Care, Research and
International Collaboration
Zhiqiang Meng, M.D.
Department of Integrative Oncology
Fudan University Cancer Center Hospital – Shanghia, China
11:05 – 11:25 AM
Holistic Dimensions of Yoga for Breast Cancer: An Update on
Research
H.R. Nagendra
Vice Chancellor
SVYASA Yoga University – Bangalore, India
11:25 – 11:45 AM
Integrative Medicine Research: Mind and Body Research –
Challenges and Opportunities
Paulo de Tarso Lima, M.D.
Integrative and Complementary Medicine
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
11:45 – 12:05 PM
A Collaborative Healthcare Program Fulfills Complex Needs
Stein Bruland, MBA
Board Manager
Vardesenteret (Place of Wellness) - Oslo, Norway
Collaboration Discussion
10:45 – 12:30 PM
Global Challenges and Opportunities Facing Women
Oncologists and Cancer Researchers: A Conversation
(Anderson Conference Hall, Rooms 1 and 2)
Elizabeth L. Travis, Ph.D., FASTRO
Associate VP, Women’s Faculty Programs
UT M.D. Anderson Cancer Center
17
Draft May 6, 2011
10:45 – 12:30 PM
International Patient Referrals
(Anderson Conference Hall, Rooms 5 and 6)
Lyle D. Green, MBA
Associate Vice President, Physician Relations
UT M.D. Anderson Cancer Center
12:30 – 2:00 PM
Lunch
Faculty Dining, R11.1620
(across from Hickey Auditorium)
2:00 – 4:30 PM
Simultaneous Break-Out Sessions
2:00 – 4:30 PM
Pediatrics (Hickey Auditorium)
Session Chair, Cesar Nunez, M.D.
Assistant Professor, Pediatrics – Patient Care
UT M.D. Anderson Cancer Center
2:00 – 2:20 PM
Children’s Cancer Hospital at MD Anderson
Eugenie Kleinerman, MD.
Division Head, Pediatrics
UT M.D. Anderson Cancer Center
2:20 – 2:40 PM
Pediatric Oncology: A Global Perspective
Cesar Nunez, M.D.
Assistant Professor, Pediatrics – Patient Care
UT M.D. Anderson Cancer Center
2:40 – 3:00 PM
Retrospective Analysis of Pediatric Anaplastic Lymphomas
Vicente Odone Filho, M.D., Ph.D.
Pediatrics
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
3:00 – 3:20 PM
*DKFZ SINF Award*
Genetic Modification of T Cells for Human Application
Cristof von Kalle, M.D.(not attending)
Translational Oncology
National Center for Tumor Diseases (NCT), German Cancer
Research Center (DKFZ) – Heidelberg, Germany
Laurence Cooper, M.D., Ph.D.
Associate Professor, Pediatrics – Patient Care
UT M.D. Anderson Cancer Center
3:20 – 3:40 PM
Concomitant Chemo-radiation in High Risk Primitive CNS
Embryonal Tumors: A Prospective Pilot Sudy at Tata
Memorial Hospital
18
Draft May 6, 2011
Purna A. Kurkure, M.D.
Prof / In charge Pediatric Oncology Division
Convenor,Pediatric Solid Tumor Group
Dept of Medical Oncology
Tata Memorial Hospital –Mumbai, India
3:40 – 4:00 PM
The Optimizing Nutrition (ON) to Life Program at Children’s
Cancer Hospital (CCH)
Joya Chandra, Ph.D.
Associate Professor, Pediatrics - Research
UT M.D. Anderson Cancer Center
Collaboration Discussion
2:00 – 4:30 PM
Micrometastasis (Anderson Conference Hall, Rooms 1 and 2)
Session Chair, James Reuben, Ph.D., MBA
Professor, Hematopathology – Research
UT M.D. Anderson Cancer Center
2:00 – 2:20 PM
Translating Human Breast Cancer Stem Cell Biology Into The
Clinic
Wendy A. Woodward, MD, PhD
Assistant Professor, Division of Radiation Oncology
UT MD Anderson Cancer Center
2:20 – 2:40 PM
The Detection of Circulating Tumor Cells in the Peripheral
Blood of Patients With Breast Cancer Using Real-time Reverse
Transcript-polymerase Chain Reaction for Cytokeratin 19
Soohyeon Lee, M.D.
Medical Oncology
Yonsei University Medical Center – Seoul, South Korea
2:40 – 3:00 PM
Molecular Detection of Micrometastases In Sentinel Lymph
Nodes Isolated From Colon Cancer Patients By An Ex Vivo
Approach
Oddmund Nordgard, Ph.D.
Senior Molecular Biologist, Department of Hematology and
Oncology
Stavenger University Hospital – Stavanger, Norway
3:00 – 3:20 PM
Detection of Minimal Residual Disease In Bone Marrow, Blood
And Plasma From Early Breast Cancer Patients Using mRNA
and microRNA Markers
Kjersti Tjensvoll, Ph.D.
Molecular Biologist, Department of Hematology and Oncology
Stavenger University Hospital – Stavanger, Norway
19
Draft May 6, 2011
3:20 – 3:40 PM
Diagnosis and Prognosis of Pancreatic Cancer By a Novel
Serum Micro RNA Expression Profile-based Biomarker
Yi Ba, MD, PhD
Director, GI Medical Oncology Department
Tianjin Medical university Cancer Institute – Tianjin, China
3:40 – 4:00 PM
Serglycin is a Theranostic Target in Nasopharyngeal
Carcinoma That Promotes Metastasis
Chao-Nan (Miles) Qian, MD, PhD,
Professor
Sun Yet-Sen University Cancer Center – Guangzhou, China
Collaboration Discussion
20